Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol
Authors
Ying‐Ying Yang (ORCID: https://orcid.org/0000-0002-7719-0397)
Xiankun Sun (ORCID: https://orcid.org/0000-0002-7690-2786)
Juan Liao (ORCID: https://orcid.org/0000-0002-0811-1077)
Lang Bai (ORCID: https://orcid.org/0000-0001-5042-4336)
Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol
Ying‐Ying Yang, Xiankun Sun, Juan Liao, Lang Bai et al.
Journal
BMJ Open
Topics
Liver Disease and Transplantation
article
Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol
Ying‐Ying Yang, Xiankun Sun, Juan Liao, Lang Bai, Ling Zhang, Zhiwen Chen, Fang Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Funders
Sichuan University, West China Hospital, Sichuan University